She Chen

1.8k total citations
53 papers, 1.3k citations indexed

About

She Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, She Chen has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in She Chen's work include MicroRNA in disease regulation (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cell death mechanisms and regulation (4 papers). She Chen is often cited by papers focused on MicroRNA in disease regulation (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Cell death mechanisms and regulation (4 papers). She Chen collaborates with scholars based in China, United States and Hong Kong. She Chen's co-authors include Si Zhang, Rui Xue, Ling Dong, Lijie Ma, Jianxin Gu, Pingping Dong, Wenqing Tang, Longzi Liu, Xizhong Shen and Guangxi Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Blood.

In The Last Decade

She Chen

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
She Chen China 22 693 308 267 206 158 53 1.3k
Xiaoling Zhou China 24 909 1.3× 249 0.8× 119 0.4× 174 0.8× 231 1.5× 83 1.6k
Shuqin Liu China 17 549 0.8× 257 0.8× 177 0.7× 188 0.9× 86 0.5× 76 1.2k
Liang Wen China 21 752 1.1× 208 0.7× 304 1.1× 231 1.1× 158 1.0× 54 1.4k
Ju-Ming Wang Taiwan 28 1.3k 1.9× 414 1.3× 455 1.7× 499 2.4× 170 1.1× 44 2.1k
Chang‐Yan Li China 21 905 1.3× 127 0.4× 206 0.8× 186 0.9× 222 1.4× 81 1.5k
Xin Wu China 19 793 1.1× 249 0.8× 232 0.9× 445 2.2× 118 0.7× 44 1.5k
Chang‐Hui Ge China 19 795 1.1× 118 0.4× 193 0.7× 177 0.9× 191 1.2× 54 1.2k
Chao‐Wen Cheng Taiwan 22 578 0.8× 249 0.8× 396 1.5× 191 0.9× 143 0.9× 65 1.4k
Sarah P. Short United States 18 605 0.9× 251 0.8× 165 0.6× 176 0.9× 61 0.4× 45 1.2k

Countries citing papers authored by She Chen

Since Specialization
Citations

This map shows the geographic impact of She Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by She Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites She Chen more than expected).

Fields of papers citing papers by She Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by She Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by She Chen. The network helps show where She Chen may publish in the future.

Co-authorship network of co-authors of She Chen

This figure shows the co-authorship network connecting the top 25 collaborators of She Chen. A scholar is included among the top collaborators of She Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with She Chen. She Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jiang, Shuoyi, et al.. (2025). USP5 deubiquitinates and stabilizes IMPDH2, to promote hepatocellular carcinoma progression. Oncogene. 44(24). 1936–1948. 1 indexed citations
3.
Lin, Xiahui, Wei Zhang, Si Zhang, et al.. (2025). 6-aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3β signals. Neoplasia. 70. 101239–101239. 1 indexed citations
4.
Zhang, Wei, Yan Zhang, Liping Han, et al.. (2024). Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase. Cardiovascular Research. 121(2). 353–366. 7 indexed citations
5.
Hu, Jialu, Renjie Chen, Yanyi Xu, et al.. (2024). Impact of fine particulate matter on liver injury: evidence from human, mice and cells. Journal of Hazardous Materials. 469. 133958–133958. 6 indexed citations
6.
Chen, Peihao, Yu Cao, Shanshan Liu, et al.. (2023). Chemical inhibition of mitochondrial fission via targeting the DRP1-receptor interaction. Cell chemical biology. 30(3). 278–294.e11. 16 indexed citations
7.
Li, Yaohua, Yannan Zhao, Wei Zhang, et al.. (2022). Immunoglobulin superfamily 9 (IGSF9) is trans-activated by p53, inhibits breast cancer metastasis via FAK. Oncogene. 41(41). 4658–4672. 7 indexed citations
8.
Wang, Xiaoxiao, Si Zhang, Pingping Dong, et al.. (2021). MRCKβ links Dasm1 to actin rearrangements to promote dendrite development. Journal of Biological Chemistry. 296. 100730–100730. 3 indexed citations
9.
Tong, Hanxing, Dongping Li, Qiuyu Jiang, et al.. (2021). The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC. Molecular Medicine. 27(1). 95–95. 4 indexed citations
10.
Li, Dianrong, Youwei Ai, Jia Guo, et al.. (2020). Casein kinase 1G2 suppresses necroptosis-promoted testis aging by inhibiting receptor-interacting kinase 3. eLife. 9. 22 indexed citations
11.
Dong, Pingping, Xiaoxiao Wang, Wenqing Tang, et al.. (2020). Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma. Journal of Hepatology. 73(6). 1446–1459. 30 indexed citations
12.
Zhao, Guangxi, Yingying Xu, Shu‐Qiang Weng, et al.. (2019). CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation. Oncogene. 38(23). 4574–4589. 31 indexed citations
13.
Chen, She, Zhizhong Li, Choong H. Lee, et al.. (2018). PARD3 dysfunction in conjunction with dynamic HIPPO signaling drives cortical enlargement with massive heterotopia. Genes & Development. 32(11-12). 763–780. 48 indexed citations
14.
Cai, Yu‐Dong, Guanqun Huang, Lijie Ma, et al.. (2017). Smurf2, an E3 ubiquitin ligase, interacts with PDE4B and attenuates liver fibrosis through miR-132 mediated CTGF inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(2). 297–308. 41 indexed citations
15.
Chen, She, Zhujun Yin, Zhanqiang Ma, et al.. (2014). Asiaticoside attenuates memory impairment induced by transient cerebral ischemia–reperfusion in mice through anti-inflammatory mechanism. Pharmacology Biochemistry and Behavior. 122. 7–15. 77 indexed citations
16.
Wu, Weibin, Xijun Liu, Xiaomin Peng, et al.. (2014). Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. Biochemical and Biophysical Research Communications. 448(1). 50–55. 21 indexed citations
17.
Yao, Qing, Li Zhang, Xiaobo Wan, et al.. (2014). Structure and Specificity of the Bacterial Cysteine Methyltransferase Effector NleE Suggests a Novel Substrate in Human DNA Repair Pathway. PLoS Pathogens. 10(11). e1004522–e1004522. 24 indexed citations
18.
Chen, She. (2003). Breeding of a New Double-low Rapeseed Cultivar Xiangyou No.15. JOURNAL OF HUNAN AGRICULTURAL UNIVERSITY. 3 indexed citations
19.
Chen, She, Xianglei Yin, Xiaoyu Zhu, et al.. (2003). The C-terminal Kinase Domain of the p34cdc2-related PITSLRE Protein Kinase (p110C) Associates with p21-activated Kinase 1 and Inhibits Its Activity during Anoikis. Journal of Biological Chemistry. 278(22). 20029–20036. 39 indexed citations
20.
Zhang, Songwen, Mingmei Cai, Si Zhang, et al.. (2002). Interaction of p58PITSLRE, a G2/M-specific Protein Kinase, with Cyclin D3. Journal of Biological Chemistry. 277(38). 35314–35322. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026